Back to top

Zacks.com Most Recent Articles

Zacks Equity Research

Is Shoe Carnival (SCVL) a Solid Growth Stock? 3 Reasons to Think " Yes "

Tale of the Tape

Shoe Carnival (SCVL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

SCVL

Zacks Equity Research

Should Value Investors Choose Chatham Lodging Trust (CLDT)?

Analyst Blog

Let's see if Chatham Lodging (CLDT) stock is a good choice for value-oriented investors right now from multiple angles.

CLDT

Zacks Equity Research

Is CBRE Group (CBRE) a Profitable Stock for Value Investors?

Analyst Blog

Let's see if CBRE Group (CBRE) stock is a good choice for value-oriented investors right now from multiple angles.

CBRE

Zacks Equity Research

Should Value Investors Pick Braemar Hotels & Resorts (BHR)?

Analyst Blog

Let's see if Braemar Hotels & Resorts (BHR) stock is a good choice for value-oriented investors right now from multiple angles.

BHR

Zacks Equity Research

Amazon's Cloud Clientele Expands as BP Migrates Data to AWS

Analyst Blog

BP goes all-in on AWS, which highlights the efficiency and reliability of Amazon's (AMZN) cloud services offerings.

BABA AMZN GOOGL MSFT

Zacks Equity Research

Is Bluerock Residential Growth (BRG) a Good Stock to Pick?

Analyst Blog

Is Bluerock Residential Growth (BRG) a great pick from the value investor's perspective right now? Read on to know more.

BRG

Zacks Equity Research

Should Value Investors Pick Ashford Hospitality (AHT) Stock?

Analyst Blog

Is Ashford Hospitality Trust (AHT) a great pick from the value investor's perspective right now? Read on to know more.

AHT

Zacks Equity Research

Costco Sustains Decent Comparable Sales Run in November

Analyst Blog

Costco's (COST) better price management and strong membership trends have been playing a crucial role in driving comps. The metric improves 5.3% during the month of November.

COST WMT TJX TGT

Zacks Equity Research

Is Annaly Capital Management (NLY) a Good Value Investor Pick?

Analyst Blog

Let's see if Annaly Capital Management (NLY) stock is a good choice for value-oriented investors right now from multiple angles.

NLY

Zacks Equity Research

Methode Electronics (MEI) Q2 Earnings & Sales Miss Estimates

Analyst Blog

Methode Electronics' (MEI) second-quarter fiscal 2020 results suffer from strike at General Motors and currency rate fluctuations.

BIDU MCHX CVLT MEI

Zacks Equity Research

Okta's (OKTA) Q3 Earnings and Revenues Surpass Estimates

Analyst Blog

Okta's (OKTA) third-quarter fiscal 2020 results benefit from new customer additions and growing international momentum driven by increasing adoption of Identity solutions.

FTNT MCHX BIDU OKTA

Zacks Equity Research

Should Value Investors Pick AGNC Investment (AGNC) Stock?

Analyst Blog

Let's see if AGNC Investment Corp. (AGNC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

AGNC

Zacks Equity Research

WM or RSG: Which Waste Management Stock Is Better Placed?

Analyst Blog

A faster share price rally over the past year leads to a rich valuation for Waste Management (WM) compared with Republic Services (RSG).

CATM GPN WM RSG

Zacks Equity Research

The Zacks Analyst Blog Highlights: uniQure, Sarepta Therapeutics, BioMarin Pharmaceutical and Sangamo Therapeutics

Press Releases

The Zacks Analyst Blog Highlights: uniQure, Sarepta Therapeutics, BioMarin Pharmaceutical and Sangamo Therapeutics

QURE BMRN SGMO SRPT

Zacks Equity Research

Is DiamondRock Hospitality (DRH) Stock a Suitable Value Pick?

Analyst Blog

Let's see if DiamondRock Hospitality Company (DRH) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

DRH

Zacks Equity Research

Biogen Up on New Data on Alzheimer's Candidate Aducanumab

Analyst Blog

Biogen (BIIB) divulges new positive data on Alzheimer's candidate, aducanumab at CTAD. Stock rises.

NVS RHHBY AMGN BIIB

Zacks Equity Research

Company News for Dec 6, 2019

Corporate Summary

Companies In The News Are: KR,DG,TIF,TD

TD DG TIF KR

Zacks Equity Research

Dave & Buster's (PLAY) to Post Q3 Earnings: What's in Store?

Analyst Blog

Dave & Buster's (PLAY) third-quarter fiscal 2019 results are likely to reflect solid sales-building initiatives and consistent expansion plans.

PLAY DNKN EAT CMG

Zacks Equity Research

Fastenal (FAST) November Sales Beat Normal Seasonal Patterns

Analyst Blog

After missing normal seasonal patterns in October by 250 bps, Fastenal (FAST) beats the seasonality by 90 bps in November.

CRMT BLDR BMCH FAST

Kinjel Shah

Pharma Stock Roundup: FDA Updates for RHHBY, AZN, MRK, No Asbestos in Talc Says JNJ

Analyst Blog

The FDA approves Roche's (RHHBY) Tecentriq for expanded use. It grants priority review status to AstraZeneca (AZN) & Merck's (MRK) supplemental applications.

GSK AZN MRK PFE RHHBY JNJ

Zacks Equity Research

Sage Therapeutics' Depression Drug Fails in Study, Stock Down

Analyst Blog

Sage Therapeutics' (SAGE) phase III study on pipeline candidate SAGE-217 for the treatment of major depressive disorder fails to meet the primary endpoint.

ANIK ALKS SAGE VTGN

Zacks Equity Research

Signet's (SIG) Q3 Loss Narrower Than Expected, Sales Beat

Analyst Blog

Signet Jewelers (SIG) reports narrower-than-expected loss and higher-than-anticipated sales in third-quarter fiscal 2020. Management lifts its top and bottom-line view for fiscal 2020.

TIF SIG DKS BOOT

Zacks Equity Research

AstraZeneca's Lynparza Gets China Nod in First-Line Setting

Analyst Blog

AstraZeneca's (AZN) Lynparza receives approval in China for first-line maintenance treatment of advanced ovarian cancer with BRCA-mutation.

GSK AZN RHHBY MRK

Zacks Equity Research

Regeneron Reports Positive Data on Rare Blood Disorder Drug

Analyst Blog

Regeneron (REGN) announces positive top-line data from a phase II study on rare blood disorder drug.

NVS BAYRY SNY REGN

Zacks Equity Research

Rent-A-Center Hikes Dividend: What Else Should You Know?

Analyst Blog

Rent-A-Center (RCII) announces a 16% hike in its quarterly dividend, taking it from 25 cents a share to 29 cents.

RCII TGT SP CRCM

Maharathi Basu

5 High-Flying Stocks After Recent Broker Rating Upgrades

Analyst Blog

Due to the complexities surrounding the investment world, it is not easy for investors to rake in profits. This is where guidance from brokers comes in handy.

AAL AN BCC MR DDS

Zacks Equity Research

Restaurant Brands' Burger King Aims to Expand in Canada

Analyst Blog

Restaurant Brands' (QSR) Burger King plans to open more than 100 restaurants in Canada.

QSR CHUY CMG DNKN

Zacks Equity Research

Michaels (MIK) Down 16% on Q3 Earnings Miss & Lower FY19 View

Analyst Blog

Michaels (MIK) reports dismal results in third-quarter fiscal 2019. Also, it lowers sales and earnings view for the current fiscal year.

HIBB DKS MIK ODP

James Giaquinto

Three Stocks from the Zacks #1 Rank Uptrends Screen

Investment Ideas

Three Stocks from the Zacks #1 Rank Uptrends Screen

VRTX DKS AMAT

Madhurima Das

Gold Mining Stocks' Near-Term Prospects Shine Bright

Industry Outlook

Uncertainties related to the United States-China trade war, geopolitical tensions and lower interest rates continue to support the yellow metal's prices, which bodes well for the gold-mining industry.

NEM KL FNV BTG AUY